{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:04:26Z","timestamp":1787166266416,"version":"build-2736575974"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to compare the effects of oliceridine, fentanyl, and sufentanil on early recovery and perioperative safety during hysteroscopic polypectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single-center, double-blind, randomized controlled trial enrolled 92 patients aged 18\u201365 with ASA I\u2013II and BMI 18\u201330 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      undergoing elective intravenous general anesthesia for the procedure. Patients were randomly assigned in a 1:1:1 ratio to the fentanyl (\n                      <jats:italic>n<\/jats:italic>\n                      = 30), sufentanil (\n                      <jats:italic>n<\/jats:italic>\n                      = 31), and oliceridine (\n                      <jats:italic>n<\/jats:italic>\n                      = 31) groups. The primary outcome was the Clinical Recovery Score (CRS) at 5, 10, and 15 min post-awakening. Secondary outcomes included time to eye opening on verbal command, time to full awakening, intraoperative vital signs, and adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The oliceridine group had significantly higher CRS at 5, 10, and 15 min after awakening than the fentanyl and sufentanil groups (overall\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.009, and\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001, respectively). The time to eye opening on verbal command was shorter in the oliceridine group than in the fentanyl and sufentanil groups (overall\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). The time to full awakening was also shorter in the oliceridine group than in the fentanyl and sufentanil groups (overall\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). At T2 (after anesthetic stabilization and before surgery), the oliceridine group had higher RR than the fentanyl and sufentanil groups (both\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), and higher SpO\n                      <jats:sub>2<\/jats:sub>\n                      than the fentanyl group (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0178). No significant differences were observed among the groups in intraoperative motor response, assisted ventilation, or rescue analgesic use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For hysteroscopic polypectomy, propofol combined with oliceridine was associated with improved early recovery outcomes and more favorable respiratory-related observations compared with fentanyl and sufentanil. These findings support the potential value of oliceridine in facilitating earlier recovery in day surgery, although confirmation in larger studies with more comprehensive physiological monitoring is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1819353","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:09:04Z","timestamp":1779430144000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of oliceridine in daytime hysteroscopic polypectomy: a randomized, double-blind, single-center controlled trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, The Fifth Clinical Medical College, Guilin Medical University","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Fifth Clinical Medical College, Guilin Medical University","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Fifth Clinical Medical College, Guilin Medical University","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Friedrich Alexander Universit\u00e4t Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Fifth Clinical Medical College, Guilin Medical University","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragyanshu","family":"Khare","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani","place":["Rajasthan, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinnan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Fifth Clinical Medical College, Guilin Medical University","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"B1","volume-title":"Endometrial Polyp","author":"Mansour","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/ijms25052557","article-title":"Transcriptomic analysis reveals intrinsic abnormalities in endometrial polyps","volume":"25","author":"Chiu","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.18502\/ijrm.v20i6.11441","article-title":"The effect of misoprostol on the removal of endometrial polyps: a pilot clinical trial","volume":"20","author":"Aflatoonian","year":"2022","journal-title":"Int J Reprod Biomed."},{"key":"B4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J Pharmacol Exp Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1124\/mol.119.119206","article-title":"Regulators of G protein signaling in analgesia and addiction","volume":"98","author":"Sakloth","year":"2020","journal-title":"Mol Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1358\/dot.2020.56.4.3107707","article-title":"Oliceridine, a G protein-selective ligand at the \u03bc-opioid receptor, for the management of moderate to severe acute pain","volume":"56","author":"Gan","year":"2020","journal-title":"Drugs Today."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.2147\/DDDT.S525471","article-title":"Overview and prospects of the clinical application of oliceridine","volume":"19","author":"Yi","year":"2025","journal-title":"Drug Des Devel Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.2147\/DDDT.S530296","article-title":"Comparison of oliceridine and morphine in postoperative analgesia in laparoscopic total hysterectomy, a randomized double-blind controlled trial","volume":"19","author":"Duan","year":"2025","journal-title":"Drug Des Devel Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.2147\/DDDT.S512529","article-title":"A comparative evaluation of the safety and efficacy of oliceridine and sufentanil in gastrointestinal endoscopy: a single-center, randomized controlled trial","volume":"19","author":"Ma","year":"2025","journal-title":"Drug Des Devel Ther."},{"key":"B10","first-page":"67","article-title":"Evaluation of a clinical recovery score after general anesthesia","volume":"40","author":"Quinn","year":"1993","journal-title":"Anesth Prog."},{"key":"B11","first-page":"2252","article-title":"The effect of modified nasopharyngeal airway preservation of spontaneous breathing under general anesthesia on postoperative recovery quality in patients undergoing day surgery with hysteroscopy","volume":"103","author":"Wang","year":"2023","journal-title":"Chin Med J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science."},{"key":"B13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain."},{"key":"B16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ALN.0000000000004473","article-title":"Respiratory effects of biased ligand oliceridine in older volunteers: a pharmacokinetic-pharmacodynamic comparison with morphine","volume":"138","author":"Simons","year":"2023","journal-title":"Anesthesiology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"111870","DOI":"10.1016\/j.jclinane.2025.111870","article-title":"Oliceridine for postoperative pain and opioid-related complications: The intravenous oliceridine and opioid-related complications (VOLITION) prospective cohort study","volume":"105","author":"Sessler","year":"2025","journal-title":"J Clin Anesth."},{"key":"B18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/ALN.0000000000003441","article-title":"Benefit and risk evaluation of biased \u03bc-receptor agonist oliceridine versus morphine","volume":"133","author":"Dahan","year":"2020","journal-title":"Anesthesiology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","volume":"32","author":"Shenoy","year":"2011","journal-title":"Trends Pharmacol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.coph.2016.11.007","article-title":"3rd, Rominger DH, Violin JD. Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics","volume":"32","author":"Siuda","year":"2017","journal-title":"Curr Opin Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-394440-5.00002-4","article-title":"True arrestins and arrestin-fold proteins: a structure-based appraisal","volume":"118","author":"Aubry","year":"2013","journal-title":"Prog Mol Biol Transl Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4939-9158-7_2","volume":"1957","author":"Laporte","year":"2019","journal-title":"Methods Mol Biol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1819353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:09:08Z","timestamp":1779430148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1819353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":23,"alternative-id":["10.3389\/fmed.2026.1819353"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1819353","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1819353"}}